AKEBIA THERAPEUTICS, INC. (AKBA)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ampco-Pittsburgh Corporation to Present at the East Coast IDEAS Investor Conference on June 10, 2026, in New York
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Fluor Joint Venture Receives Limited Notice to Proceed for Proposed Phase 2 Expansion of LNG Canada Facility
New Era Energy & Digital Strengthens Leadership Team with Appointments of Evan Pierce as Chief Development Officer and Michael Johnson as General Counsel and Chief Compliance Officer
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
Definium Therapeutics Announces New Employee Inducement Grants
Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference
Sonoco Releases Corporate Sustainability Report Highlighting Progress and Award-Winning Products
Thornburg Income Builder Opportunities Trust Announces Distribution